3.Epidemiology, diagnosis and treatment of Middle East respiratory syndrome.
Journal of Zhejiang University. Medical sciences 2015;44(4):443-450
Middle East respiratory syndrome (MERS) has raised global public health concerns. The recent outbreak of MERS coronavirus (MERS-CoV) infection has led to 1 338 laboratory-confirmed cases in 26 countries worldwide as reported till 19 June, 2015. MERS-CoV may be considered a zoonotic virus that has crossed the species barrier to humans, but the pathogenesis and the routes of transmission are not completely understood. Most MERS-CoV cases reported thus far have a history of residence in or travel to the Middle East. Human-to-human transmission though was observed on some occasions in Korea, it is documented as non-sustainable event. The envelope spike glycoprotein on the surface of MERS-CoV which mediates receptor binding, membrane fusion and viral entry is thought to be involved in the mechanism of MERS-CoV.No specific and effective treatment for MERS-CoV is currently recommended, although supportive treatment has played an important role. Prophylactic strategies are necessary to prevent MERS-CoV infection.
Coronavirus Infections
;
diagnosis
;
epidemiology
;
therapy
;
Humans
;
Middle East Respiratory Syndrome Coronavirus
;
pathogenicity
;
physiology
;
Spike Glycoprotein, Coronavirus
;
metabolism
;
Virus Internalization
4.Spike protein in the detection and treatment of novel coronavirus.
Journal of Biomedical Engineering 2020;37(2):246-250
Recently a COVID-19 pneumonia pandemic caused by a novel coronavirus 2019-nCoV has broken out over the world. In order to better control the spread of the pandemic, there's an urgent need to extensively study the virus' origin and the mechanisms for its infectivity and pathogenicity. Spike protein is a special structural protein on the surface of coronavirus. It contains important information about the evolution of the virus and plays critical roles in the processes of cellular recognition and entry. In the past decades, spike protein has always been one of the most important objects in research works on coronaviruses closely related to human life. In this review we introduce these research works related to spike proteins, hoping it will provide reasonable ideas for the control of the current pandemic, as well as for the diagnosis and treatment of COVID-19.
Betacoronavirus
;
Coronavirus Infections
;
diagnosis
;
therapy
;
Evolution, Molecular
;
Humans
;
Pandemics
;
Pneumonia, Viral
;
diagnosis
;
therapy
;
Spike Glycoprotein, Coronavirus
;
analysis
5.Glucocorticoid for coronavirus disease 2019: a dilemma.
Chinese Critical Care Medicine 2020;32(3):278-278
6.Significance and operation mode of moxibustion intervention for the group under quarantine after close contact with COVID-19.
Mai-Lan LIU ; Mi LIU ; Huan ZHONG ; Jie YU ; Jian LUO ; Kun AI ; Ming XU ; Qiong LIU ; Guo-Bin DAI ; Wei ZHANG ; Hong ZHANG ; Xiao-Rong CHANG ; Bao-Yan LIU
Chinese Acupuncture & Moxibustion 2020;40(5):457-461
On the base of the idea of traditional Chinese medicine as "disease prevention", the mode and the protocol of the moxibustion intervention for the group under quarantine after close contact with coronavirus disease 2019 (COVID-19) were explored. The group under quarantine after close contact with COVID-19 was taken as the subjects. By the non-contact physician-patient communication network platform co-developed by China Association of Acupuncture-Moxibustion, Hunan Provincial Association of Acupuncture-Moxibustion, Data Center of China Academy of Chinese Medical Sciences and Yuge Medicine Company, an exploratory randomized controlled trial was designed. A total of 100 cases were included and randomized into a moxibustion group and a conventional intervention group, 50 cases in each one. In the moxibustion group, moxibustion intervention was used. In the conventional intervention group, the conventional observation was adopted without moxibusiton intervention applied. The outcomes included the symptoms changes, e.g. anxiety, emotional disturbance, fatigue, headache and diarrhea, as well as whether quarantine release and the case confirmed or not, etc. The results were evaluated before intervention, in 14 days of intervention and 2 weeks after intervention separately. In this research, on the base of internet plus technology and with the internet communication platform adopted, through mobile phone WeChat App, it was to implement the subject screen, the random allocation and the instruction of moxibustion intervention as well as the quality control of patient's diary and data collection. It is anticipated that the significance and the implementation mode of moxibustion intervention can be assessed preliminarily for the group under quarantine after close contact with COVID-19.
Acupuncture Therapy
;
methods
;
Betacoronavirus
;
China
;
Coronavirus Infections
;
therapy
;
Humans
;
Moxibustion
;
Pandemics
;
Pneumonia, Viral
;
therapy
;
Quarantine
7.Small molecular agents against MERS-CoV infection.
Xiao-yun ZENG ; Lu LU ; Shi-bo JIANG ; Shu-wen LIU
Acta Pharmaceutica Sinica 2015;50(12):1520-1526
Middle East respiratory syndrome coronavirus (MERS-CoV) has caused outbreaks of SARS-like disease with 35% case-fatality rate, mainly in the Middle East. A more severe outbreak of MERS occurred recently in the Republic of Korea, where 186 people contracted the infections, causing great concern worldwide. So far, there has been no clinically available drug for the treatment of MERS-CoV infection. The potential drugs against MERS-CoV mainly consist of monoclonal antibodies, peptides and small molecular agents. Small molecular agents have an advantage of easier synthesis, lower cost in production and relatively higher stability. There is better chance for those candidates to gain a quick development. This article reviews the progress of developing small molecular MERS-CoV agents.
Antibodies, Monoclonal
;
pharmacology
;
Antiviral Agents
;
pharmacology
;
Coronavirus Infections
;
drug therapy
;
Drug Design
;
Humans
;
Middle East Respiratory Syndrome Coronavirus
;
drug effects
8.Dangers of scientific bias against herbal drugs for coronavirus disease 2019.
Journal of Integrative Medicine 2020;18(6):459-461
On May 15, 2020, the Lancet published an article titled Use of Herbal Drugs to Treat COVID-19 Should be with Caution. While this is true of all drugs, herbal and otherwise, the data may be biased and deserve a scientific response. We believe these types of reports will unfairly and negatively impact the field of integrative medicine as a whole, and must be answered with facts and statistics that more accurately represent the current situation.
Betacoronavirus
;
Bias
;
COVID-19
;
Coronavirus
;
Coronavirus Infections/drug therapy*
;
Drugs, Chinese Herbal
;
Humans
;
Pandemics
;
Pneumonia, Viral
;
SARS-CoV-2
9.Practice and System Construction of Telemedicine for Coronavirus Disease 2019 Epidemic Prevention and Control.
Jing FAN ; Hong-Yi LIN ; Ming-Wei QIN
Acta Academiae Medicinae Sinicae 2020;42(4):531-534
Telemedicine is one of the five key components of the "Internet Plus Healthcare".Due to its high speed,real-timeness,low cost,and wide spread,telemedicine is highly feasible in the prevention and control of major infectious diseases.This article introduces the practiceof telemedicine in Peking Union Medical College Hospital during the cornavirus disease 2019(COVID-19)epidemic,during which the network resources were applied to break geographical restrictions and resolve communication barriers between hospitals and departments.This article summarizes the telemedicine application before,during and after COVID-19 control and elucidates how to build a telemedicine prevention and control system for infectious diseases,with an attempt to further improve telemedicine and is application in the public health emergency system in China.
Betacoronavirus
;
Coronavirus Infections
;
drug therapy
;
Humans
;
Pandemics
;
Pneumonia, Viral
;
drug therapy
;
Telemedicine